|
1）Shaw PJ, Bates D. Conservative treatment of delayed cerebral radiation necrosis. J Neurol Neurosurg Psychiatry. 1984; 47: 1338-41
|
|
|
|
2）Glantz MJ, Burger PC, Friedman AH, et al. Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology. 1994; 44: 2020-7
|
|
|
|
|
|
3）Bui QC, Lieber M, Withers HR, et al. The efficacy of hyperbaric oxygen therapy in the treatment of radiation-induced late side effect. Int J Rad Oncol Biol Phys. 2004; 60: 871-8
|
|
|
|
|
|
4）Truong MT, St Clair EG, Donahue BR, et al. Results of surgical resection for progression of brain metastases previously treated by gamma knife radiosurgery. Neurosurygery. 2006; 59: 86-97
|
|
|
|
|
|
5）McPherson CM, Warnick RE. Results of contemporary surgical management of radiation necrosis using frameless stereotaxis and intraoperative magnetic resonance imaging. J Neurooncol. 2004; 68: 41-7
|
|
|
|
|
|
6）Nordal RA, Nagy A, Pintilie M, et al. Hypoxia and hypoxia-inducible factor-1 target genes in central nervous system radiation injury: A role for vascular endothelial growth factor. Clin Cancer Res. 2004; 10: 3342-53
|
|
|
|
|
|
7）Nonoguchi N, Miyatake S, Fukumoto M, et al. The distribution of vascular endothelial growth factor-producing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles. J Neurooncol. 2011; 105: 423-31
|
|
|
|
|
|
8）Gonzalez J, Kumar AJ, Conrad CA, et al. Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys. 2007; 67: 323-6
|
|
|
|
|
|
9）Wong ET, Huberman M, Lu XQ, et al. Bevacizumab reverses cerebral radiation necrosis. J Clin Oncol. 2008; 26: 5649-50
|
|
|
|
|
|
10）Torcuator R, Zuniga R, Mohan YS, et al. Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. J Neurooncol. 2009; 94: 63-8
|
|
|
|
|
|
11）Levin VA, Bidaut L, Hou P, et al. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys. 2011; 79: 1487-95
|
|
|
|
|
|
12）Furuse M, Kawabata S, Kuroiwa T, et al. Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: A report of 2 cases. J Neurooncol. 2011; 102: 471-5
|
|
|
|
|
|
13）Liu AK, Macy ME, Foreman NK. Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas. Int J Radiat Oncol Biol Phys. 2009; 75: 1148-54
|
|
|
|
|
|
14）Jeyaretna DS, Curry Jr WT, Batchelor TT, et al. Exacerbation of cerebral radiation necrosis by bevacizumab. J Clin Oncol. 2011; 29: e159-62
|
|
|
|
|
|
15）Matuschek C, Bolke E, Nawatny J, et al. Bevacizumab as a treatment option for radiation-induced cerebral necrosis. Strahlenther und Onkol. 2011; 87: 135-9
|
|
|
|
|
|
16）Benoit A, Ducray F, Cartalat-Carel S, et al. Favorable outcome with bevacizumab after poor outcome with steroids in a patient with temporal lobe and brainstem radiation necrosis. J Neurol. 2011; 258: 328-9
|
|
|
|
|
|
17）Miyashita M, Miyatake SI, Imahori Y, et al. Evaluation of fluoride-labeled boronophenyl-alanine-PET imaging for the study of radiation effects in patients with glioblastomas. J Neurooncol. 2008; 89: 239-46
|
|
|
|
|